0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
EV-Based Liquid Biopsy Market by Product Type, Technology, Application, Disease Indication, End User - Global Forecast to 2030- Product Image
EV-Based Liquid Biopsy Market by Product Type, Technology, Application, Disease Indication, End User - Global Forecast to 2030- Product Image
Sale

EV-Based Liquid Biopsy Market by Product Type, Technology, Application, Disease Indication, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924680
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The EV-Based Liquid Biopsy Market is rapidly advancing as a leading force in non-invasive diagnostic technologies, enabling organizations to respond to rising demands for early disease detection and precision medicine.

Market Snapshot: EV-Based Liquid Biopsy Market

The global EV-Based Liquid Biopsy Market grew from USD 473.12 million in 2024 to USD 550.93 million in 2025. It is projected to sustain strong momentum, expanding at a CAGR of 15.99% and reaching USD 1.15 billion by 2030. Market growth is driven by technological upgrades, diversified clinical applications, and increased investment in non-invasive diagnostic solutions across regions with strong research, clinical, and healthcare infrastructure.

Scope & Segmentation

This report provides comprehensive coverage of the EV-Based Liquid Biopsy Market, detailing the landscape across product offerings, technology domains, disease targets, and key regions. Stakeholders will find actionable insights into the following market segments:

  • Product Types: Instruments and platforms, kits and reagents, services (including analytical and sample preparation solutions).
  • Technology: Enzyme-linked immunosorbent assays (ELISA), flow cytometry, microarray, nanoparticle assays, next-generation sequencing (NGS), quantitative PCR (qPCR).
  • Application: Companion diagnostics, early cancer detection, prognosis and monitoring, research use.
  • Disease Indications: Breast cancer, colorectal cancer, lung cancer, prostate cancer.
  • End User: Diagnostic laboratories, hospitals and clinics, pharmaceutical companies, research centers.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, United Arab Emirates, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, Southeast Asia, and more).
  • Key Players: Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Techne Corporation, Miltenyi Biotec GmbH, Takara Bio Inc., NanoView Biosciences, Inc., HansaBioMed Life Sciences Ltd., Norgen Biotek Corp., System Biosciences LLC, BioVision, Inc.

Key Takeaways for Senior Decision-Makers

  • Extracellular vesicle (EV) liquid biopsy is transforming diagnostics by providing sensitive and specific molecular insights from simple blood or fluid samples, which supports personalized clinical strategies and better outcomes.
  • Continuous innovation in EV profiling instruments and reagents drives improvement in workflow, reproducibility, and scalability for both clinical and research applications.
  • The market strongly benefits from convergence of high-throughput screening, artificial intelligence, and advanced analytical platforms, accelerating multiomic data integration and actionable results.
  • Regulatory momentum grows as governments clarify guidelines and introduce structured reimbursement pathways, supporting faster clinical adoption and market access.
  • Strategic partnerships and vertical integration among technology providers, pharmaceutical firms, and research institutions strengthen the commercialization pipeline and streamline solution delivery for end users.
  • Regional market approaches must adapt to differences in healthcare infrastructure, regulatory maturity, and resource allocation, particularly as emerging economies scale up diagnostic capacity through partnerships and innovation initiatives.

Tariff Impact: Implications of 2025 US Tariffs

The 2025 United States tariffs have introduced cost pressures across the EV-based liquid biopsy value chain, especially on imported reagents, precision instruments, and consumables from Asia and Europe. Providers are now reassessing procurement and supply chain strategies, adopting localized assembly and diversifying supplier qualifications to sustain operations and mitigate exposure to trade policy shifts. Pharmaceutical firms are also broadening R&D collaboration across regions to reduce supply risk and leverage varying trade terms. Industry stakeholders increasingly prioritize automation and innovative reagent formulation to drive resilience despite pricing volatility.

Methodology & Data Sources

Market insights are drawn from a rigorous blend of secondary research—covering peer-reviewed publications, regulatory, and corporate filings—and structured primary interviews with leaders from diagnostic laboratories, pharmaceutical R&D, and academia. The methodology includes data triangulation, peer review, and ongoing validation to ensure accuracy and relevance.

Why This Report Matters

  • Informs strategic investments by offering a breakdown of growth opportunities across product, technology, and regional segments in the EV-Based Liquid Biopsy Market.
  • Supports executive decision-making with actionable analysis on regulatory trends, tariff impacts, and competitive positioning.
  • Guides market-entry and partnership strategies by revealing key innovation areas, unmet needs, and evolving end user priorities.

Conclusion

Senior leaders leveraging this analysis will be prepared to drive innovation, overcome supply chain complexity, and capture meaningful growth in the evolving EV-based diagnostics arena. The market’s multi-dimensional landscape demands continuous alignment with technology advances and emerging clinical standards.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. EV-Based Liquid Biopsy Market, by Product Type
8.1. Introduction
8.2. Instruments and Platforms
8.2.1. Flow Cytometers
8.2.2. NGS Platforms
8.2.3. qPCR Instruments
8.3. Kits and Reagents
8.3.1. Detection Kits
8.3.2. Isolation Kits
8.3.3. Labeling Reagents
8.4. Services
8.4.1. Analytical Services
8.4.2. Sample Preparation Services
9. EV-Based Liquid Biopsy Market, by Technology
9.1. Introduction
9.2. ELISA
9.3. Flow Cytometry
9.4. Microarray
9.5. Nanoparticle Assays
9.6. NGS
9.7. qPCR
10. EV-Based Liquid Biopsy Market, by Application
10.1. Introduction
10.2. Companion Diagnostics
10.3. Early Cancer Detection
10.4. Prognosis and Monitoring
10.5. Research
11. EV-Based Liquid Biopsy Market, by Disease Indication
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
12. EV-Based Liquid Biopsy Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Hospitals and Clinics
12.4. Pharmaceutical Companies
12.5. Research Centers
13. Americas EV-Based Liquid Biopsy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa EV-Based Liquid Biopsy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific EV-Based Liquid Biopsy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. QIAGEN N.V.
16.3.3. Bio-Techne Corporation
16.3.4. Miltenyi Biotec GmbH
16.3.5. Takara Bio Inc.
16.3.6. NanoView Biosciences, Inc.
16.3.7. HansaBioMed Life Sciences Ltd.
16.3.8. Norgen Biotek Corp.
16.3.9. System Biosciences LLC
16.3.10. BioVision, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EV-BASED LIQUID BIOPSY MARKET MULTI-CURRENCY
FIGURE 2. EV-BASED LIQUID BIOPSY MARKET MULTI-LANGUAGE
FIGURE 3. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EV-BASED LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DETECTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ISOLATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NANOPARTICLE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROGNOSIS AND MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 63. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 64. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 73. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 113. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 120. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 122. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 136. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 137. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 141. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 144. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 145. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 146. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 149. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 176. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 177. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 181. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 192. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 193. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 194. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 197. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 201. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 202. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 205. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 224. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 225. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 226. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 229. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 232. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 233. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 234. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 237. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 248. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 250. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 253. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 256. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 257. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 258. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 261. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 279. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 281. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 282. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 283. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 286. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 289. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 290. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 291. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 294. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 298. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 299. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 302. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 327. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS AND PLATFORMS, 2018-2030 (USD MILLION)
TABLE 329. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 330. THAILAND EV-BASED LIQUID BIOPSY MA

Samples

Sample File DOWNLOAD NOW

Companies Mentioned

The companies profiled in this EV-Based Liquid Biopsy market report include:
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Bio-Techne Corporation
  • Miltenyi Biotec GmbH
  • Takara Bio Inc.
  • NanoView Biosciences, Inc.
  • HansaBioMed Life Sciences Ltd.
  • Norgen Biotek Corp.
  • System Biosciences LLC
  • BioVision, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 550.93 Million
Forecasted Market Value ( USD ) by 2030 $ 1150 Million
Compound Annual Growth Rate15.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast to 2030 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market by Technology, Application, End User, Test Type, Sample Type, Indication, Distribution Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Breast Cancer Liquid Biopsy Global Market Report 2025 - Product Image

Breast Cancer Liquid Biopsy Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Breast Cancer Liquid Biopsy - Global Strategic Business Report - Product Image

Breast Cancer Liquid Biopsy - Global Strategic Business Report

  • Report
  • 217 Pages
  • Global
From
EUR$5,850USDGBP
Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Cancer Biopsy Market Size, Share and Trends Analysis Report by Type (Liquid Biopsy, Core Needle Biopsy), Application (Breast Cancer, Lung Cancer), Product (Kits & Consumables, Instruments), and Region 2024-2030 - Product Image

Cancer Biopsy Market Size, Share and Trends Analysis Report by Type (Liquid Biopsy, Core Needle Biopsy), Application (Breast Cancer, Lung Cancer), Product (Kits & Consumables, Instruments), and Region 2024-2030

  • Report
  • 150 Pages
  • Global
From
EUR$5,950USDGBP

About the Market

The EV Based Liquid Biopsy market is a rapidly growing segment of the pharmaceutical industry. It is a type of non-invasive diagnostic test that uses circulating cell-free extracellular vesicles (EVs) to detect and monitor cancer. EVs are released from cells into the bloodstream and can be used to detect cancer-specific biomarkers, providing a more accurate diagnosis than traditional methods. This technology has the potential to revolutionize cancer diagnosis and treatment, as it can detect cancer at an earlier stage and provide more precise information about the disease. EV Based Liquid Biopsy is also being used to monitor the effectiveness of cancer treatments, as well as to detect and monitor other diseases such as cardiovascular disease and neurological disorders. This technology is being used in clinical trials and is expected to become more widely available in the near future. Some companies in the EV Based Liquid Biopsy market include Exosome Diagnostics, Exosomics, Exosome Sciences, and Exosome Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more